STRATA Skin Sciences, Inc.

NasdaqCM:SSKN Stock Report

Market Cap: US$12.0m

STRATA Skin Sciences Management

Management criteria checks 2/4

STRATA Skin Sciences' CEO is Dolev Rafaeli, appointed in Oct 2023, has a tenure of 1.25 years. total yearly compensation is $986.12K, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 3.43% of the company’s shares, worth $412.29K. The average tenure of the management team and the board of directors is 2 years and 6.7 years respectively.

Key information

Dolev Rafaeli

Chief executive officer

US$986.1k

Total compensation

CEO salary percentage6.8%
CEO tenure1.3yrs
CEO ownership3.4%
Management average tenure2yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

Investors Don't See Light At End Of STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Tunnel And Push Stock Down 30%

Aug 18
Investors Don't See Light At End Of STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Tunnel And Push Stock Down 30%

Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?

Aug 07
Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?

STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Shares Lagging The Industry But So Is The Business

Jun 07
STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Shares Lagging The Industry But So Is The Business

Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?

Mar 19
Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?

STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Dec 31
STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?

Nov 03
Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?

We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt

Jul 04
We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Stock Rockets 26% But Many Are Still Ignoring The Company

Apr 18
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Stock Rockets 26% But Many Are Still Ignoring The Company

Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?

Jan 14
Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?

STRATA Skin Sciences GAAP EPS of -$0.05 in-line, revenue of $9.1M beats by $0.96M

Aug 10

Strata Skin stock soars ~18% after hours on U.S. commercial launch of acne treatment

Jul 25

What Type Of Returns Would STRATA Skin Sciences'(NASDAQ:SSKN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Mar 09
What Type Of Returns Would STRATA Skin Sciences'(NASDAQ:SSKN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Reflecting on STRATA Skin Sciences' (NASDAQ:SSKN) Share Price Returns Over The Last Five Years

Nov 24
Reflecting on STRATA Skin Sciences' (NASDAQ:SSKN) Share Price Returns Over The Last Five Years

CEO Compensation Analysis

How has Dolev Rafaeli's remuneration changed compared to STRATA Skin Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$9m

Jun 30 2024n/an/a

-US$8m

Mar 31 2024n/an/a

-US$11m

Dec 31 2023US$986kUS$67k

-US$11m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$7m

Mar 31 2023n/an/a

-US$6m

Dec 31 2022n/an/a

-US$6m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$6m

Mar 31 2022n/an/a

-US$3m

Dec 31 2021US$283kUS$271k

-US$3m

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$6m

Dec 31 2020US$593kUS$412k

-US$4m

Sep 30 2020n/an/a

-US$4m

Jun 30 2020n/an/a

-US$4m

Mar 31 2020n/an/a

-US$3m

Dec 31 2019US$1mUS$400k

-US$4m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019n/an/a

-US$3m

Mar 31 2019n/an/a

-US$3m

Dec 31 2018US$3mUS$289k

-US$4m

Compensation vs Market: Dolev's total compensation ($USD986.12K) is above average for companies of similar size in the US market ($USD645.26K).

Compensation vs Earnings: Dolev's compensation has increased whilst the company is unprofitable.


CEO

Dolev Rafaeli (60 yo)

1.3yrs

Tenure

US$986,121

Compensation

Dr. Dolev Rafaeli, Ph D., serves as Vice-Chairman, President and Chief Executive Officer at STRATA Skin Sciences, Inc. since October 30, 2023. He served as Chief Executive Officer, President and Director o...


Leadership Team

NamePositionTenureCompensationOwnership
Dolev Rafaeli
President1.3yrsUS$986.12k3.43%
$ 412.3k
Shmuel Gov
Chief Operating Officer2.8yrsUS$683.79k1.12%
$ 134.6k
John Gillings
Principal Financial Officer & Principal Accounting Officerless than a yearno datano data
Jay Sturm
General Counsel & Corporate Secretaryno datano datano data
Michael Stewart
Independent Consultant8.2yrsUS$732.90kno data

2.0yrs

Average Tenure

65.5yo

Average Age

Experienced Management: SSKN's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Dolev Rafaeli
President1.3yrsUS$986.12k3.43%
$ 412.3k
Daniel Lufkin
Director Emeritus14.8yrsUS$28.62kno data
Uri Geiger
Independent Chairman6.7yrsUS$80.00kno data
R. Anderson
Member of Scientific Advisory Board7.7yrsUS$10.25kno data
Irit Yaniv
Independent Director1.3yrsUS$13.87kno data
Christina Allgeier
Directorno dataUS$48.33kno data
Samuel Rubinstein
Independent Director6.7yrsUS$87.20k0.44%
$ 52.8k

6.7yrs

Average Tenure

60yo

Average Age

Experienced Board: SSKN's board of directors are considered experienced (6.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 23:54
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

STRATA Skin Sciences, Inc. is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gregory ChodaczekBoenning & Scattergood, Inc.
Jose Teodorico De Jesus HarescoBrean Capital
null nullCG Capital